Obesity Decreases Hepatic 25-Hydroxylase Activity Causing Low Serum 25-Hydroxyvitamin D

Jeffrey D. Roizen, Caela Long, Alex Casella, Lauren O'Lear, Ilana Caplan, Meizan Lai, Issac Sasson, Ravinder Jit Singh, Andrew J. Makowski, Rebecca Simmons, Michael A. Levine

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Normal vitamin D homeostasis is critical for optimal health; nevertheless, vitamin D deficiency is a worldwide public health problem. Vitamin D insufficiency is most commonly due to inadequate cutaneous synthesis of cholecalciferol and/or insufficient intake of vitamin D, but can also arise as a consequence of pathological states such as obesity. Serum concentrations of 25(OH)D (calcidiol) are low in obesity, and fail to increase appropriately after vitamin D supplementation. Although sequestration of vitamin D in adipose tissues or dilution of ingested or cutaneously synthesized vitamin D in the large fat mass of obese patients has been proposed to explain these findings, here we investigate the alternative mechanism that reduced capacity to convert parent vitamin D to 25(OH)D due to decreased expression of CYP2R1, the principal hepatic vitamin D 25-hydroxylase. To test this hypothesis, we isolated livers from female mice of 6 to 24 weeks of age, weaned onto either a normal chow diet or a high-fat diet, and determined the abundance of Cyp2r1 mRNA using digital droplet-quantitative PCR. We observed a significant (p < 0.001) decrease in Cyp2r1 mRNA in the liver of high-fat diet–fed mice relative to lean-chow–fed female mice. Moreover, there was a significant (p < 0.01) relationship between levels of Cyp2r1 mRNA and serum 25(OH)D concentrations as well as between Cyp2R1 mRNA and the ratio of circulating 25(OH)D3 to cholecalciferol (p < 0.0001). Using linear regression we determined a curve with 25(OH)D3/cholecalciferol versus normalized Cyp2R1 mRNA abundance with an R2 value of 0.85. Finally, we performed ex vivo activity assays of isolated livers and found that obese mice generated significantly less 25(OH)D3 than lean mice (p < 0.05). Our findings indicate that expression of CYP2R1 is reduced in obesity and accounts in part for the decreased circulating 25(OH)D.

Original languageEnglish (US)
Pages (from-to)1068-1073
Number of pages6
JournalJournal of Bone and Mineral Research
Volume34
Issue number6
DOIs
StatePublished - Jun 1 2019

Fingerprint

Mixed Function Oxygenases
Vitamin D
Obesity
Liver
Serum
Cholecalciferol
Messenger RNA
Fats
Calcifediol
Obese Mice
Vitamin D Deficiency
25-hydroxyvitamin D
High Fat Diet
Adipose Tissue
Linear Models
Homeostasis
Public Health
Diet
Polymerase Chain Reaction
Skin

Keywords

  • CYP2R1
  • OBESITY
  • P450
  • VITAMIN D

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Orthopedics and Sports Medicine

Cite this

Roizen, J. D., Long, C., Casella, A., O'Lear, L., Caplan, I., Lai, M., ... Levine, M. A. (2019). Obesity Decreases Hepatic 25-Hydroxylase Activity Causing Low Serum 25-Hydroxyvitamin D. Journal of Bone and Mineral Research, 34(6), 1068-1073. https://doi.org/10.1002/jbmr.3686

Obesity Decreases Hepatic 25-Hydroxylase Activity Causing Low Serum 25-Hydroxyvitamin D. / Roizen, Jeffrey D.; Long, Caela; Casella, Alex; O'Lear, Lauren; Caplan, Ilana; Lai, Meizan; Sasson, Issac; Singh, Ravinder Jit; Makowski, Andrew J.; Simmons, Rebecca; Levine, Michael A.

In: Journal of Bone and Mineral Research, Vol. 34, No. 6, 01.06.2019, p. 1068-1073.

Research output: Contribution to journalArticle

Roizen, JD, Long, C, Casella, A, O'Lear, L, Caplan, I, Lai, M, Sasson, I, Singh, RJ, Makowski, AJ, Simmons, R & Levine, MA 2019, 'Obesity Decreases Hepatic 25-Hydroxylase Activity Causing Low Serum 25-Hydroxyvitamin D', Journal of Bone and Mineral Research, vol. 34, no. 6, pp. 1068-1073. https://doi.org/10.1002/jbmr.3686
Roizen, Jeffrey D. ; Long, Caela ; Casella, Alex ; O'Lear, Lauren ; Caplan, Ilana ; Lai, Meizan ; Sasson, Issac ; Singh, Ravinder Jit ; Makowski, Andrew J. ; Simmons, Rebecca ; Levine, Michael A. / Obesity Decreases Hepatic 25-Hydroxylase Activity Causing Low Serum 25-Hydroxyvitamin D. In: Journal of Bone and Mineral Research. 2019 ; Vol. 34, No. 6. pp. 1068-1073.
@article{f35b7542c08f4acb9d8472b0aa692071,
title = "Obesity Decreases Hepatic 25-Hydroxylase Activity Causing Low Serum 25-Hydroxyvitamin D",
abstract = "Normal vitamin D homeostasis is critical for optimal health; nevertheless, vitamin D deficiency is a worldwide public health problem. Vitamin D insufficiency is most commonly due to inadequate cutaneous synthesis of cholecalciferol and/or insufficient intake of vitamin D, but can also arise as a consequence of pathological states such as obesity. Serum concentrations of 25(OH)D (calcidiol) are low in obesity, and fail to increase appropriately after vitamin D supplementation. Although sequestration of vitamin D in adipose tissues or dilution of ingested or cutaneously synthesized vitamin D in the large fat mass of obese patients has been proposed to explain these findings, here we investigate the alternative mechanism that reduced capacity to convert parent vitamin D to 25(OH)D due to decreased expression of CYP2R1, the principal hepatic vitamin D 25-hydroxylase. To test this hypothesis, we isolated livers from female mice of 6 to 24 weeks of age, weaned onto either a normal chow diet or a high-fat diet, and determined the abundance of Cyp2r1 mRNA using digital droplet-quantitative PCR. We observed a significant (p < 0.001) decrease in Cyp2r1 mRNA in the liver of high-fat diet–fed mice relative to lean-chow–fed female mice. Moreover, there was a significant (p < 0.01) relationship between levels of Cyp2r1 mRNA and serum 25(OH)D concentrations as well as between Cyp2R1 mRNA and the ratio of circulating 25(OH)D3 to cholecalciferol (p < 0.0001). Using linear regression we determined a curve with 25(OH)D3/cholecalciferol versus normalized Cyp2R1 mRNA abundance with an R2 value of 0.85. Finally, we performed ex vivo activity assays of isolated livers and found that obese mice generated significantly less 25(OH)D3 than lean mice (p < 0.05). Our findings indicate that expression of CYP2R1 is reduced in obesity and accounts in part for the decreased circulating 25(OH)D.",
keywords = "CYP2R1, OBESITY, P450, VITAMIN D",
author = "Roizen, {Jeffrey D.} and Caela Long and Alex Casella and Lauren O'Lear and Ilana Caplan and Meizan Lai and Issac Sasson and Singh, {Ravinder Jit} and Makowski, {Andrew J.} and Rebecca Simmons and Levine, {Michael A.}",
year = "2019",
month = "6",
day = "1",
doi = "10.1002/jbmr.3686",
language = "English (US)",
volume = "34",
pages = "1068--1073",
journal = "Journal of Bone and Mineral Research",
issn = "0884-0431",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Obesity Decreases Hepatic 25-Hydroxylase Activity Causing Low Serum 25-Hydroxyvitamin D

AU - Roizen, Jeffrey D.

AU - Long, Caela

AU - Casella, Alex

AU - O'Lear, Lauren

AU - Caplan, Ilana

AU - Lai, Meizan

AU - Sasson, Issac

AU - Singh, Ravinder Jit

AU - Makowski, Andrew J.

AU - Simmons, Rebecca

AU - Levine, Michael A.

PY - 2019/6/1

Y1 - 2019/6/1

N2 - Normal vitamin D homeostasis is critical for optimal health; nevertheless, vitamin D deficiency is a worldwide public health problem. Vitamin D insufficiency is most commonly due to inadequate cutaneous synthesis of cholecalciferol and/or insufficient intake of vitamin D, but can also arise as a consequence of pathological states such as obesity. Serum concentrations of 25(OH)D (calcidiol) are low in obesity, and fail to increase appropriately after vitamin D supplementation. Although sequestration of vitamin D in adipose tissues or dilution of ingested or cutaneously synthesized vitamin D in the large fat mass of obese patients has been proposed to explain these findings, here we investigate the alternative mechanism that reduced capacity to convert parent vitamin D to 25(OH)D due to decreased expression of CYP2R1, the principal hepatic vitamin D 25-hydroxylase. To test this hypothesis, we isolated livers from female mice of 6 to 24 weeks of age, weaned onto either a normal chow diet or a high-fat diet, and determined the abundance of Cyp2r1 mRNA using digital droplet-quantitative PCR. We observed a significant (p < 0.001) decrease in Cyp2r1 mRNA in the liver of high-fat diet–fed mice relative to lean-chow–fed female mice. Moreover, there was a significant (p < 0.01) relationship between levels of Cyp2r1 mRNA and serum 25(OH)D concentrations as well as between Cyp2R1 mRNA and the ratio of circulating 25(OH)D3 to cholecalciferol (p < 0.0001). Using linear regression we determined a curve with 25(OH)D3/cholecalciferol versus normalized Cyp2R1 mRNA abundance with an R2 value of 0.85. Finally, we performed ex vivo activity assays of isolated livers and found that obese mice generated significantly less 25(OH)D3 than lean mice (p < 0.05). Our findings indicate that expression of CYP2R1 is reduced in obesity and accounts in part for the decreased circulating 25(OH)D.

AB - Normal vitamin D homeostasis is critical for optimal health; nevertheless, vitamin D deficiency is a worldwide public health problem. Vitamin D insufficiency is most commonly due to inadequate cutaneous synthesis of cholecalciferol and/or insufficient intake of vitamin D, but can also arise as a consequence of pathological states such as obesity. Serum concentrations of 25(OH)D (calcidiol) are low in obesity, and fail to increase appropriately after vitamin D supplementation. Although sequestration of vitamin D in adipose tissues or dilution of ingested or cutaneously synthesized vitamin D in the large fat mass of obese patients has been proposed to explain these findings, here we investigate the alternative mechanism that reduced capacity to convert parent vitamin D to 25(OH)D due to decreased expression of CYP2R1, the principal hepatic vitamin D 25-hydroxylase. To test this hypothesis, we isolated livers from female mice of 6 to 24 weeks of age, weaned onto either a normal chow diet or a high-fat diet, and determined the abundance of Cyp2r1 mRNA using digital droplet-quantitative PCR. We observed a significant (p < 0.001) decrease in Cyp2r1 mRNA in the liver of high-fat diet–fed mice relative to lean-chow–fed female mice. Moreover, there was a significant (p < 0.01) relationship between levels of Cyp2r1 mRNA and serum 25(OH)D concentrations as well as between Cyp2R1 mRNA and the ratio of circulating 25(OH)D3 to cholecalciferol (p < 0.0001). Using linear regression we determined a curve with 25(OH)D3/cholecalciferol versus normalized Cyp2R1 mRNA abundance with an R2 value of 0.85. Finally, we performed ex vivo activity assays of isolated livers and found that obese mice generated significantly less 25(OH)D3 than lean mice (p < 0.05). Our findings indicate that expression of CYP2R1 is reduced in obesity and accounts in part for the decreased circulating 25(OH)D.

KW - CYP2R1

KW - OBESITY

KW - P450

KW - VITAMIN D

UR - http://www.scopus.com/inward/record.url?scp=85066496418&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066496418&partnerID=8YFLogxK

U2 - 10.1002/jbmr.3686

DO - 10.1002/jbmr.3686

M3 - Article

VL - 34

SP - 1068

EP - 1073

JO - Journal of Bone and Mineral Research

JF - Journal of Bone and Mineral Research

SN - 0884-0431

IS - 6

ER -